You can buy or sell PLSE and other stocks, options, ETFs, and crypto commission-free!
Pulse Biosciences, Inc. operates as an immuno-oncology company developing a proprietary oncolytic electroceutical therapy based on its Nano Pulse Stimulation (NPS) technology. It manufactures surgical and medical instruments uses a novel and proprietary platform technology called Nano-Pulse Electro-Signaling. Read More The NPES provides local tumor control and initiates an adaptive immune response with a vaccine-like effect by inducing immunogenic apoptosis of the cells. The company was founded on May 19, 2014 and is headquartered in Hayward, CA. The listed name for PLSE is Pulse Biosciences, Inc Common Stock (DE).
52 Week High
52 Week Low
— per share
Expected Nov 5, After Hours